Profits at hospice firm VITAS soar by whopping nearly 88 percent in Q4
03/05/24 at 03:00 AM
Profits at hospice firm VITAS soar by whopping nearly 88 percent in Q4
McKnights Home Care, by Adam Healy; 2/29/24
Hospice firm VITAS, a subsidiary of Chemed, enjoyed a stellar fourth quarter as profits rose by nearly 88% to reach $63 million. It helped to buoy Chemed’s overall earnings as the parent company’s other subsidiary, plumbing subsidiary Roto-Rooter, struggled with weaker profits and sales.